Edwards gains CE mark for 29 mm aortic heart valve

Edwards Lifesciences has received a CE mark for its 29 mm version of the Sapien XT transcatheter aortic heart valve, which will be made available with the company’s Ascendra transapical delivery system.

The valve will now be available in three sizes to serve a larger patient population and the device incorporates a tissue leaflet design and cobalt chromium frame to improve radial strength.

Sapien XT was commercially launched in Europe in 2010, but its efficacy and safety is still being studied in the U.S. within the PARTNER II randomized controlled trial.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.